CCP approves acquisition of two Japanese pharma products by Hilton Pharma
Proposed transaction entails the acquisition of Methycobal and Myonal including their trademarks
Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?
The pharmaceutical company has had a torrid history. The new development could prove to be its redemption
Citi Pharma, Hangzhou Newsea partner to boost local API manufacturing
With an expected annual turnover of Rs15,000m, the JV underscores a push towards reducing import dependence and enhancing local manufacturing infrastructure in Pakistan’s pharmaceutical industry
Despite deregulated prices, Searle swings to a loss
Price increases were not enough to compensate for increases in operating costs, despite a gross profit margin expansion
Macter gaining market share, and diversifying into cosmetics
The biopharmaceutical manufacturer saw revenue growth faster than industry average, and also plans to launch a GLP 1 product
LCCI demands DRAP to form a liaison committee
LAHORE: The Lahore Chamber of Commerce and Industry (LCCI) has demanded from the Drug Regulatory Authority of Pakistan (DRAP) to form a liaison committee...
Do cures harm the drug business?
OTTAWA: "Is curing patients a sustainable business model?" That provocative question was posed on page 38 of a Goldman Sachs research report on biotechnology...
Pak pharma industry suffers from government’s shackles
A thriving sector in Pakistan’s economy, pharmaceuticals is a $3.2 billion industry, growing at 15% annually, while its exports now at $US200 million are...
Citi Pharma’s veterinary subsidiary begins operations, launching 32 products initially
Citi Veterinary Limited projects a turnover of Rs 1.5 billion for FY 2025-26, with plans to establish Pakistan's first dedicated veterinary Active Pharmaceutical Ingredient (API) plant
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Transparency International says some branded medicines in Pakistan cost up to 4,000% more than generics
Transparency International Pakistan urges government to implement generic medicine policy to address significant price disparities between branded and non-branded drugs
DRAP orders urgent recall of substandard medicines, medical products
Contaminated injections, syrups, and IV cannulas flagged; crackdown launched nationwide
Panadol costs more now. What has this meant for the pharma industry?
Haleon has benefited from the new drug pricing policy introduced by DRAP and it shows in its financial results
Fate of Pfizer’s consumer business in spotlight after Merck sells its unit
NEW YORK: With the sale of Merck's consumer healthcare business to Procter & Gamble, the spotlight now shifts to the fate of Pfizer's consumer healthcare unit,...
Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh
Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh.
Clarifying its position, the company stated,...
